205 related articles for article (PubMed ID: 22006831)
1. Association between sclerostin and bone density in chronic spinal cord injury.
Morse LR; Sudhakar S; Danilack V; Tun C; Lazzari A; Gagnon DR; Garshick E; Battaglino RA
J Bone Miner Res; 2012 Feb; 27(2):352-9. PubMed ID: 22006831
[TBL] [Abstract][Full Text] [Related]
2. Circulating sclerostin is elevated in short-term and reduced in long-term SCI.
Battaglino RA; Sudhakar S; Lazzari AA; Garshick E; Zafonte R; Morse LR
Bone; 2012 Sep; 51(3):600-5. PubMed ID: 22575440
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin: a candidate biomarker of SCI-induced osteoporosis.
Morse LR; Sudhakar S; Lazzari AA; Tun C; Garshick E; Zafonte R; Battaglino RA
Osteoporos Int; 2013 Mar; 24(3):961-8. PubMed ID: 22801952
[TBL] [Abstract][Full Text] [Related]
4. Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Maïmoun L; Ben Bouallègue F; Gelis A; Aouinti S; Mura T; Philibert P; Souberbielle JC; Piketty M; Garnero P; Mariano-Goulart D; Fattal C
Bone; 2019 Oct; 127():612-619. PubMed ID: 31351195
[TBL] [Abstract][Full Text] [Related]
5. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury.
Zhao W; Li X; Peng Y; Qin Y; Pan J; Li J; Xu A; Ominsky MS; Cardozo C; Feng JQ; Ke HZ; Bauman WA; Qin W
Calcif Tissue Int; 2018 Oct; 103(4):443-454. PubMed ID: 29931461
[TBL] [Abstract][Full Text] [Related]
7. Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
Qin W; Zhao W; Li X; Peng Y; Harlow LM; Li J; Qin Y; Pan J; Wu Y; Ran L; Ke HZ; Cardozo CP; Bauman WA
Osteoporos Int; 2016 Dec; 27(12):3627-3636. PubMed ID: 27436301
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.
Invernizzi M; Carda S; Rizzi M; Grana E; Squarzanti DF; Cisari C; Molinari C; Renò F
Spinal Cord; 2015 Aug; 53(8):615-20. PubMed ID: 25896346
[TBL] [Abstract][Full Text] [Related]
9. Osteocytes reflect a pro-inflammatory state following spinal cord injury in a rodent model.
Metzger CE; Gong S; Aceves M; Bloomfield SA; Hook MA
Bone; 2019 Mar; 120():465-475. PubMed ID: 30550849
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.
Qin W; Li X; Peng Y; Harlow LM; Ren Y; Wu Y; Li J; Qin Y; Sun J; Zheng S; Brown T; Feng JQ; Ke HZ; Bauman WA; Cardozo CC
J Bone Miner Res; 2015 Nov; 30(11):1994-2004. PubMed ID: 25974843
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.
Battaglino RA; Lazzari AA; Garshick E; Morse LR
Curr Osteoporos Rep; 2012 Dec; 10(4):278-85. PubMed ID: 22983921
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss.
Beggs LA; Ye F; Ghosh P; Beck DT; Conover CF; Balaez A; Miller JR; Phillips EG; Zheng N; Williams AA; Aguirre JI; Wronski TJ; Bose PK; Borst SE; Yarrow JF
J Bone Miner Res; 2015 Apr; 30(4):681-9. PubMed ID: 25359699
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
[TBL] [Abstract][Full Text] [Related]
14. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
Polyzos SA; Anastasilakis AD; Bratengeier C; Woloszczuk W; Papatheodorou A; Terpos E
Osteoporos Int; 2012 Mar; 23(3):1171-6. PubMed ID: 21305266
[TBL] [Abstract][Full Text] [Related]
15. Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.
Roforth MM; Fujita K; McGregor UI; Kirmani S; McCready LK; Peterson JM; Drake MT; Monroe DG; Khosla S
Bone; 2014 Feb; 59():1-6. PubMed ID: 24184314
[TBL] [Abstract][Full Text] [Related]
16. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
17. Circulating sclerostin in disorders of parathyroid gland function.
Costa AG; Cremers S; Rubin MR; McMahon DJ; Sliney J; Lazaretti-Castro M; Silverberg SJ; Bilezikian JP
J Clin Endocrinol Metab; 2011 Dec; 96(12):3804-10. PubMed ID: 21937621
[TBL] [Abstract][Full Text] [Related]
18. Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.
Ma YH; Schwartz AV; Sigurdsson S; Hue TF; Lang TF; Harris TB; Rosen CJ; Vittinghoff E; Eiriksdottir G; Hauksdottir AM; Siggeirsdottir K; Sigurdsson G; Oskarsdottir D; Napoli N; Palermo L; Gudnason V; Li X
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2584-90. PubMed ID: 25144629
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the efficacy of functional electrical stimulation therapy assisted walking after chronic motor incomplete spinal cord injury: effects on bone biomarkers and bone strength.
Craven BC; Giangregorio LM; Alavinia SM; Blencowe LA; Desai N; Hitzig SL; Masani K; Popovic MR
J Spinal Cord Med; 2017 Nov; 40(6):748-758. PubMed ID: 28929919
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.
Doherty AL; Battaglino RA; Donovan J; Gagnon D; Lazzari AA; Garshick E; Zafonte R; Morse LR
J Bone Miner Res; 2014 Jan; 29(1):251-9. PubMed ID: 23787489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
